Literature DB >> 16127315

Length of the ECT course in bipolar and unipolar depression.

Harold A Sackeim, Joan Prudic.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16127315     DOI： 10.1097/01.yct.0000176972.72777.c4

Source DB:  PubMed          Journal:  J ECT        ISSN： 1095-0680            Impact factor:   3.635


× No keyword cloud information.
  7 in total

1.  Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.

Authors:  Charles H Kellner; Mustafa M Husain; Rebecca G Knapp; W Vaughn McCall; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shirlene Sampson; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Peter B Rosenquist; Ahmad Raza; Styliani Kaliora; Vassilios Latoussakis; Kristen G Tobias; Mimi C Briggs; Lauren S Liebman; Emma T Geduldig; Abeba A Teklehaimanot; Sarah H Lisanby
Journal:  Am J Psychiatry       Date:  2016-07-15       Impact factor: 18.112

Review 2.  Speed of antidepressant response to electroconvulsive therapy in bipolar disorder vs. major depressive disorder.

Authors:  Smita Agarkar; Stephen W Hurt; Robert C Young
Journal:  Psychiatry Res       Date:  2018-03-01       Impact factor: 3.222

3.  Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.

Authors:  Eric L Ross; Kara Zivin; Daniel F Maixner
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

4.  Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.

Authors:  Cinara Ludvig Gonçalves; Helena Mendes Abelaira; Thayse Rosa; Airam Barbosa de Moura; Deise Cristina Veron; Laura Araújo Borba; Maria Eduarda Mendes Botelho; Mariana Pereira Goldim; Leandro Garbossa; Maria Eduarda Fileti; Fabricia Petronilho; Zuleide Maria Ignácio; João Quevedo; Gislaine Zilli Réus
Journal:  Pharmacol Rep       Date:  2021-01-03       Impact factor: 3.024

5.  A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT).

Authors:  Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

Review 6.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

Review 7.  Promising avenues of therapeutics for bipolar illness.

Authors:  Robert M Post
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.